ProCE Banner Activity

Optimal Assessment and Management of Agitation in Alzheimer’s Disease

Clinical Thought

How can healthcare professionals identify and manage agitation associated with Alzheimer’s disease? In this expert commentary, Susan Scanland, MSN, CRNP, GNP-BC, provides insight on various clinical strategies to optimize care of patients with AAD.

Released: May 05, 2023

Share

Faculty

Susan Scanland

Susan Scanland, MSN, CRNP, GNP-BC, CDP

National Dementia Expert
CEO and Founder, Dementia Connections LLC
Clarks Summit, Pennsylvania 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Otsuka America Pharmaceutical, Inc. and Lundbeck

Faculty Disclosure

Primary Author

Susan Scanland, MSN, CRNP, GNP-BC, CDP

National Dementia Expert
CEO and Founder, Dementia Connections LLC
Clarks Summit, Pennsylvania 

Susan Scanland, MSN, CRNP, GNP-BC: consultant/advisor/speaker: Acadia, Eisai, Genentech, Otsuka/Lundbeck, Teva.